NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Obj Ltd (ASX: OBJ)

 
OBJ Technical Analysis
3
As on 1st Nov 2017 OBJ Share Price closed @ 0.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.06 & Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

OBJ Share Price

Open 0.04 Change Price %
High 0.04 1 Day 0.01 33.33
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month 0.00 0.00
Volume 3007400 1 Year -0.03 -42.86
52 Week High 0.08 | 52 Week Low 0.03
 
ASX Australia Most Active Stocks
COE 0.30 3.45%
GPP 0.02 0.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
BPT 1.05 7.14%
PNX 0.01 0.00%
PIO 0.03 0.00%
DJS 3.99 0.00%
KSO 0.40 3900.00%
 
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
XST 0.02 100.00%
XST 0.02 100.00%
ATP 0.03 50.00%
ATP 0.03 50.00%
PMQ 0.03 50.00%
RMI 0.03 50.00%
RMI 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
 
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
GDY 0.01 -50.00%
 
 
OBJ
Daily Charts
OBJ
Intraday Charts
Whats New @
Bazaartrend
OBJ
Free Analysis
 
OBJ Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
SUPPORT0.00
SUPPORT0.00
 
OBJ Target for Month October
4th UP TARGET0.05
3rd UP TARGET0.04
2nd UP TARGET0.04
1st UP TARGET0.04
1st DOWN TARGET0.02
2nd DOWN TARGET0.02
3rd DOWN TARGET0.02
4th DOWN TARGET0.01
 
OBJ Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
OBJ Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
OBJ Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website >
 
OBJ Address
OBJ
284 Oxford Street
Ground floor
Leederville, WA 6007
Australia
Phone: 61 8 9443 3011
Fax: 61 8 9443 3866
 
OBJ Latest News
 
Your Comments and Response on Obj Ltd
 
OBJ Business Profile
OBJ Limited, together with its subsidiaries, is engaged in research and development of magnetic enhanced and magnetic micro-array drug delivery technologies for use in the pharmaceutical, cosmetic, consumer healthcare, and surface hygiene applications. It offers various technology platforms, including eM-patch, a film based micro-array technology for patches, masks, dressings, and other topical applications; Field in Motion, a magnetic micro-array film for use in brushes, scrubs, wipes, applicators, and various other products; and Dermaportation, a precision delivery system for repeat, extended usage, and multi-formulation delivery applications for a range of medical, consumer, household, and consumer needs. The company also provides partnering services for the creation of products in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient and peptide delivery; oral health strips, applicators, and tooth brushes; haircare enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It operates in Australia, the United Kingdom, Europe, the United States, and Southeast Asia. OBJ Limited is based in Leederville, Australia.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service